G
Generate Biomedicines
Generative AI for Protein Design
Somerville, MA
300+
About Generate Biomedicines
Industry:
TechBio
Founded:
2018
Founders:
Flagship Pioneering spin-out
Status:
Private
Funding & Growth
Total Raised:
$750M+
Valuation:
$1.8B+
Stage:
Series C
Key Investors:
Flagship Pioneering
Amgen
Arch Venture
✓ Pros
- • Cutting-edge generative AI for biology
- • Flagship Pioneering ecosystem
- • Boston/Cambridge location
- • World-class ML talent
- • Strong funding runway
✗ Cons
- • Very early stage
- • High bar for hiring
- • Startup uncertainty
- • Competitive ML hiring market